EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxford Nanopore-Based Genomic Characterization of Macrolide Resistance in Clinical Streptococcus pyogenes Isolates

Serkan Kaydaş, Asuman Akar, Ayla Behnejad Kazancık, Nida Özcan

Antibiotics · 18.11.2026 · 15 (11) · 1148

DOI: 10.3390/antibiotics15111148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 18.11.2026. Verfasst von Serkan Kaydaş und 3 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dicle University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Streptococcus pyogenes (Group A Streptococcus, GAS) remains a major human pathogen. This study aimed to determine the phenotypic profiles of macrolide resistance in S. pyogenes isolates from southeastern Turkey and to investigate underlying genotypic mechanisms using Oxford Nanopore sequencing.

Methods

A total of 83 clinical isolates of S. pyogenes were collected between January 2024 and June 2025. Antimicrobial susceptibility was assessed by disk diffusion following EUCAST guidelines (Breakpoint Tables v15.0). Macrolide resistance phenotypes [inducible MLSB (iMLSB), constitutive MLSB (cMLSB), and M phenotype] were determined by the D-zone test. Whole-genome sequencing of erythromycin-resistant isolates was performed using Oxford Nanopore technology, and resistance determinants were analyzed with ResFinder pipeline.

Results

All isolates were susceptible to penicillin. Six isolates (7.2%) exhibited erythromycin resistance: three iMLSB, two cMLSB, and one M phenotype. All three adult isolates were iMLSB, whereas the pediatric isolates comprised one M and two cMLSB phenotypes; given the small number of isolates, no conclusion on age-related differences can be drawn. Genotypic analysis revealed erm(A) in all iMLSB isolates, mef(A)/msr(D) in the M phenotype, and the absence of acquired macrolide resistance genes in cMLSB isolates. Co-occurrence of tetracycline resistance genes (tetM/O) was observed in four of the six isolates.

Conclusions

Penicillin remains the cornerstone of GAS therapy; however, macrolide resistance persists through diverse mechanisms. The coexistence of erm(A)-mediated iMLSB, mef(A)/msr(D)-associated M phenotype, and unexplained cMLSB resistance highlights the need for routine D-testing and genomic surveillance. These findings emphasize the importance of integrating phenotypic and genotypic approaches to monitor resistance evolution in GAS.

Förderung

  • Dicle University

Zitieren

APA

Kaydaş, S., Akar, A., Kazancık, A. B., & Özcan, N. (2026). Oxford Nanopore-Based Genomic Characterization of Macrolide Resistance in Clinical Streptococcus pyogenes Isolates. Antibiotics, 15(11), 1148. https://doi.org/10.3390/antibiotics15111148

Vancouver

Kaydaş S, Akar A, Kazancık AB, Özcan N. Oxford Nanopore-Based Genomic Characterization of Macrolide Resistance in Clinical Streptococcus pyogenes Isolates. Antibiotics. 2026;15(11):1148. doi:10.3390/antibiotics15111148

BibTeX
@article{Kayda2026,
  author = {Kaydaş, Serkan and Akar, Asuman and Kazancık, Ayla Behnejad and Özcan, Nida},
  title = {Oxford Nanopore-Based Genomic Characterization of Macrolide Resistance in Clinical Streptococcus pyogenes Isolates},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1148},
  doi = {10.3390/antibiotics15111148}
}
Kostenlos starten →